Showing results (91-100 of 251) with videos related to
Sort By:
Pageof 26
Plos One|August 17, 2022
Rural-urban outcome differences associated with COVID-19 hospitalizations in North CarolinaSheri Denslow, Jason R Wingert, Amresh D Hanchate, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 14, 2023
Timing of sedation and patient-reported pain outcomes during cardiac catheterization: Results from the UNTAP-intervention studyAnna Mall, T Andrew Girton, Kevin Yardley, et al.Vascular Medicine (London, England)|April 10, 2018
Ticagrelor in Peripheral Artery Disease Endovascular Revascularization (TI-PAD): Challenges in clinical trial executionR Kevin Rogers, William R Hiatt, Manesh R Patel, et al.Clinical Cardiology|December 10, 2014
The impact of processes of care on myocardial infarct size in patients with ST-segment elevation myocardial infarction: observations from the CRISP-AMI trialW Schuyler Jones, Robert M Clare, Karen Chiswell, et al.Journal of the American College of Cardiology|May 7, 2013
Socioeconomic disparities in the use of cardioprotective medications among patients with peripheral artery disease: an analysis of the American College of Cardiology's NCDR PINNACLE RegistrySumeet Subherwal, Manesh R Patel, Fengming Tang, et al.Journal of Vascular Surgery|January 11, 2019
Ankle-brachial index in patients with intermittent claudication is a poor indicator of patient-centered and clinician-based evaluations of functional statusAbigail L Johnston, Sreekanth Vemulapalli, Kensey L Gosch, et al.American Heart Journal|May 20, 2022
Empagliflozin in patients post myocardial infarction rationale and design of the EMPACT-MI trialJosephine Harrington, Jacob A Udell, W Schuyler Jones, et al.JACC. Cardiovascular Interventions|November 24, 2018
Predictors and Outcomes of Staged Versus One-Time Multivessel Revascularization in Multivessel Coronary Artery Disease: Insights From the VA CART ProgramPeter T Hu, W Schuyler Jones, Thomas J Glorioso, et al.JACC. Cardiovascular Interventions|March 10, 2018
Public Health Impact of the Centers for Medicare and Medicaid Services Decision on Pass-Through Add-On Payments for Drug-Coated Balloons: A Call to ActionMehdi H Shishehbor, Michael R Jaff, Joshua A Beckman, et al.Diabetes, Obesity & Metabolism|February 16, 2024
Comparative analysis of hospitalization risk for incident heart failure in non-Hispanic Black versus non-Hispanic White individuals with type 2 diabetes on empagliflozin (Empa-AA): Insights from real-world dataBasem M Mishriky, Doyle M Cummings, Yuanyuan Fu, et al.Pageof 26